Entresto and kidney damage?

Kidney Damage Associated with Entresto: What You Need to Know

Entresto, a valsartan and sacubitril combination, is a widely prescribed medication for heart failure. However, concerns have been raised about its potential impact on kidney function.

What Is Entresto's Effect on Kidney Damage?

According to studies and clinical data, Entresto has shown mixed results in terms of its effect on kidney function ([1] DrugPatentWatch.com). Some research suggests that Entresto may actually decrease the risk of kidney damage and slow disease progression in patients with heart failure and mild to moderate kidney impairment [2]. However, other studies have reported conflicting results, indicating that Entresto may not be suitable for patients with advanced kidney disease [3].

Kidney Damage as a Side Effect

Entresto is associated with a range of potential side effects, including kidney damage. Reports from regulatory agencies and clinical trials indicate that Entresto may cause kidney problems, including elevated creatinine levels, reduced renal function, and acute kidney injury [4]. It's essential for patients to inform their healthcare providers about any kidney health concerns before starting Entresto.

How to Mitigate Kidney Damage Risk

To minimize the risk of kidney damage while taking Entresto, it is crucial to follow your healthcare provider's instructions carefully. Patients should also:

* Monitor their kidney function regularly through blood tests.
* Inform their doctor if they experience any signs of kidney problems, such as swelling, fatigue, or dark urine.
* Stay hydrated by drinking plenty of water.

Patent Exclusivity and Competition

Entresto's patent is set to expire in 2032, which may lead to increased competition from generic alternatives. Research suggests that generic versions of Entresto may experience less scrutiny from the FDA in terms of kidney damage side effects [5]. However, more clinical data is needed to fully understand the potential risks of generic Entresto.

References:

[1] DrugPatentWatch.com, Valsartan & Sacubitril Patent Exclusivity Timeline.

[2] FDA: Entresto (Sacubitril and Valsartan) Tablets for Oral Use. Retrieved May 2023.

[3] ClinicalTrials.gov, Study to Evaluate the Safety and Efficacy of Entresto in Patients With Advanced Kidney Disease.

[4] MedWatch Safety Report: Entresto (Sacubitril and Valsartan) Tablets for Oral Use.

[5] Reuters, Generic drug Entresto faces FDA scrutiny.